Live Breaking News & Updates on Trademark office patent full text

Dennis Crouch, our colleague at
Patently-O, tweeted last week that there have been 148 U.S. patents granted having disclosure related to (COVID-19
or SARS-CoV-2);
With regard to issues involving the proposed WTO IP waiver (
see "If the Devil of the WTO IP Waiver Is in the Details, What Are the Details?"), it may be instructive to inspect the relatively few (4) of these patents directed to COVID-19 specific vaccines (another 4 were directed to therapeutic antibodies).  These are set forth in this table:
Of these, the only assignee associated with an actual, in-development SARS-CoV-2 vaccine is Novavax; however, the company has delayed its application for Emergency Use Authorization (EUA) from this month to sometime in the third quarter of this year (although maintaining that there is nothing troubling about the delay).

Dennis-crouch , Mcdonnell-boehnen-hulbert-berghoff , Tillis-asks-biden-administration-to-oppose , Drug-administration , Trademark-office-patent , Mcdonnell-boehnen-hulbert , Trademark-office-patent-full-text , Image-database , What-are , Emergency-use-authorization , Bad-idea , That-wont-achieve-its-desired